Skip to main content

COVID-19 Topic Center

FDA News Expert Insights

Pharmacy Learning Network
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means for care access, and how they foresee this new indication…
Pharmacy Learning Network
Tom Kraus, vice president of government relations, ASHP, discusses the recent Department of Health and Human Services (HHS) announcement that allows inactive pharmacists along with pharmacy interns to join the vaccinator force—explaining that as the vaccine supply increases, these additional…
Pharmacy Learning Network
Michael Ganio, PharmD, senior director of Pharmacy Practice and Quality, ASHP, breaks down the importance of centralized leadership and clear onsite roles within mass COVID-19 vaccine locations, highlighting the pitfalls that should be avoided during the setup of these sites and how to prevent…
Pharmacy Learning Network
By Tom Kraus, Vice President of Government Relations, ASHP  We’ve reached an important milestone in combatting the COVID-19 global pandemic: there are now three viable vaccines against SARS-CoV-2 in the US.  All three FDA-authorized vaccines have – based on the available evidence – proven…
Pharmacy Learning Network
By Douglas L. Jennings, PharmD, FACC, FAHA, FCCP, FHFSA, BCPS Volume 1, Issue 1 “Brevity is the soul of wit.” Welcome to the first installment of “Talking Therapeutics!” Each week we’re going to tackle a timely therapeutic topic by breaking it down into bite-sized talking points. The goal is to…
Pharmacy Learning Network
By Julie Gould  Adnan Iqbal, CEO and co-founder, Luma Health, identifies what is lacking in vaccine delivery and operations, and offers tips for health administrators and health systems that are looking to improve their vaccine rollout.   Can you talk a little about what is lacking in vaccine…
Pharmacy Learning Network
By Yvette C. Terrie B.S. Pharm, R.Ph., Consultant Pharmacist There is still great debate among many individuals about the efficacy and safety of COVID-19 vaccines and healthcare providers including pharmacists are likely to encounter many patients seeking their guidance and advice about the…
Pharmacy Learning Network
By Douglas L. Jennings, PharmD, FACC, FAHA, FCCP, FHFSA, BCPS In less than 12 months since the pandemic began, we have had two vaccines with Emergency Use Authorization from the FDA made available to the American public. This is truly a watershed moment for the scientific community as a whole, and…
Pharmacy Learning Network
By Yvette C Terrie, BS Pharm, RPh, Consultant Pharmacist This year all eyes have been focused on the development and pending approval of a COVID-19 vaccine. In a press release from December 11, 2020, the manufacturers, Pfizer and BioNTech SE announced that the FDA authorized the emergency use of…
Pharmacy Learning Network
By Julie Gould  Sonia Jacob, PharmD, first‑year fellow, Rutgers University/Johnson & Johnson, discusses her recent study that evaluated pharmacists’ perceptions of a COVID-19 vaccine and the associated determinants that may impact a pharmacist’s perceptions of either receiving or recommending…
Back to Top